Professional Documents
Culture Documents
E-mail: youpeng.chen@163.com
2018 年 4 月 9 日
Hemorrhagic Fever With Renal Syndrome
2
Contents
• Definition
• Etiology
• Epidemiology
• Pathogenesis
• Clinical Manifestations
• Laboratory tests
• Treatment
• Prevention
• Case report
Definition
HFRS, also called epidemic hemorrhagic fever,
Korean hemorrhage fever.
Infectious diseases with natural source
Caused by Hantaviruses
Characterized by fever, hemorrhage,
proteinuria, shock and acute renal
failure.
Five phases in the typical cases
Febrile phase, Hypotensive (shock) phase,
Oliguric phase, Diuretic phase, Convalescent phase
4
Epidemic Hemorrhagic Fever ( EHF)
5
Etiology
Hantaviruses belong to the family
Bunyaviridae
Spherical enveloped viruses with about 80-
120nm in diameter
are enveloped RNA viruses with a negative-
sense, tri-segmented genome which consists of
three single-stranded RNA segments.
S (small): encodes neucleocapsid protein
7
Etiology
9
Epidemiology
History of HFRS
• While Hantavirus pulmonary syndrome (HPS)
has only been identified since 1993, HFRS has
a much longer and complex history.
• HFRS may have been recognized in China as
early as 1000 years ago.
• HFRS described in 1913 Russian records.
10
Epidemiology
Recent HFRS Cases
• HFRS is endemic in a belt from Norway in the
west, through Sweden, Finland, the Soviet
Union, China, Korea to Japan in the east.
• China is one of the most seriously affected
countries in the world.
• About 50 000 to 100 000 cases occurred
annually from 1980-2000, 20 000 to 40 000 cases
occurred annually after 2001.
11
Geographical distribution of pathogenic hantaviruses and principal associated
pathologies in humans. HCPS = hantavirus cardiopulmonary syndrome; HFRS = haemorrhagic
12
fever with renal syndrome; NE = nephropathia epidemica
Geographical distribution of hantaviruses
16
Source of infection
• Animals: more than 170 species of animal found
carrying hantavirus.
• Rodent animals such as mice are mainly the source of
infection.
• Other animals: dogs, cats and rabbits.
• Those pathogenic species hosted by moles( 鼹鼠 ),
shrews( 象鼩 ) and bats are of doubtful pathogenicity.
• Patients: Humans are considered dead-end hosts.
17
Source of infection
• Striped field mouse (Apodemus agrarius, 黑线姬鼠 ) and Mus
norvegicus (Rattus norvegicus, 褐家鼠 ) are mainly
indentified in China.
• Apodemus sylvaticus( 大林姬鼠 ) are observed
mainly in regions of forest.
18
Striped field mouse
Apodemus sylvaticus 19
Routes of transmission: Five
1>Airborne spread: inhaling aerosols of rodent
excreta.
5>Vertical transmission
mother to baby, very rare
22
Susceptible People
• All of the people are susceptible.
• The disease appears to most frequently affected
persons of 20 to 50 years old.
• Although the disease occurs in both sexes, the
figures accumulated show a higher prevalence in
males.
• Low incidence rate of covert infection (3.5-4.3%).
• Stable and persistent immunity after infection.
23
Pathogenesis
• The pathogenesis of HFRS is unclear yet.
incompletely understood!
▲ Virus is the initiator
▲ Immune responses, humoral immunity
and cellular immunity responses, both
involves in the pathogenesis.
24
Pathogenesis
1.Direct damage by Hantan virus
Virus infection---replication in infected cells,
especially in microvascular endothelial cells
(endotheliocytes) of small blood vessels---
damage on cells.
2. Immune-mediated damage
Type III,I,II, and IV hypersensitivity reactions;
CTL reaction-mediated damage;
Cytokine-mediated cells damage
25
1>Type III hypersensitivity reaction
Hantan virus infection—induce specific
antibodies—immune complex-activating
complements-accumulation of immune
complex in small blood vessels,
basement of glomeruli and renal tubules---
damage
26
2> Other hypersensitivity reaction
Type IV--
macrophage—cytokins:
necrosis factor(TNF)—damage
28
Pathophysiology
1. Shock
2. Hemorrhage
29
Pathophysiology: shock
Immune mediated Massive hemorrhage
vascular endothelial injury or
Secondary infection
Increased capillary or
permeability Insufficient
water-electrolyte supply
Plasma extravasation during polyuric stage
▲Other organs
Such as heart, liver and
brains, so on.
34
2. Pathological features
pathological changes
Endotheliocytes of small blood vessel
congestion, edema,
hemorrhage, necrosis.
pathognomonic lesion of HFRS in kidneys.
40
HFRS: Febrile Phase
Kidney damage signs
Proteinuria, sometimes with casts, blood
cells and membrane-shaped substance
consisting of protein, blood cells and
mucosal epithelia.
41
HFRS: Febrile Phase
• It often has severe abdominal pain because of
the extensive mesentery congestion and
edema. It is often misdiagnosed “acute
abdomen”.
• When the body temperature drops, the
condition deteriorates AND the disease goes
progress (“ 热退病进” ).
It differs from other infectious disease.
42
Drunken face
Subconjunctival hemorrhage Chemosis
[ke‘məʊsɪs] 结膜水肿
Petechiae on the soft palate
Petechiae on axilla
Ecchymosis in severe case
HFRS: Hypotensive phase
• Lasts for several hours or days
• Blood pressure decrease, hypovolemia,
shock (primary shock)
• Worsening of bleeding manifestations:
petechiae, epistaxis, gastrointestinal and
intracranial bleeding
• Levels of urea and creatinine in blood rise,
proteinuria, leukocytosis, thrombocytopenia.
33% of all HFRS deaths are linked to multi-organ
hypoperfusion at this stage
HFRS: Oliguric Phase
49
HFRS: Oliguric Phase
• Onset of renal failure
Symptoms associated with uremia
Water-sodium retention
↑ , Cr ↑
• Severe complications: cardiac failure,
pulmonary edema, and cerebral bleeding.
50% of the fatality during this phase
50
HFRS: Diuretic Phase
• Lasts a few days to a few weeks.
• Characterized by diuresis and hyposthenuria
• migratory stage: 400-2000 ml/d, although the
urine output increases, blood urea and
creatinine still rise.
• earlier polyuric stage: more than 2000 ml/d,
azotemia does not improve, the symptoms
are still severe.
• later polyuric stage: more than 3000 ml/d, the
urine output increases per day, the azotemia
improve.
hyposthenuria [haɪpɒsθɪ'njʊərɪə] 低渗尿
51
azotemia[æzə'ti:mɪə] 氮质血症
HFRS: Diuretic Phase
54
1. Mild type:
T< 39℃, mild intoxication
symptoms without oliguria
and shock
55
2. Moderate:
T>39℃ , severe intoxicating
symptoms, drunkenness,
conjunctiva edema,
hemorrhage, hypotension,
oliguria and marked proteinuria.
56
3. Severe:
T>40℃, more severe intoxicating
symptoms, shock, bleeding,
oliguria for less than 5 days or
anuria for less than 2 days.
57
4. Very serious:
The symptoms and signs in
severe type with one of following
six signs:
1>. hard-corrective Shock
2>. Bleeding in main organ
3>. Acute renal failure
4>. Cardiac failure
pulmonary edema
5>. Complication in central nervous system
6>. Serious secondary infection
58
5. Atypical
59
Laboratory test
• Blood Routine: a normal or slightly decreased WBC
count in some patients
leukocytosis, 15-50x 109/L in a few instances
neutrophils dominated in early stage,
lymphocytes in late stage.
Atypical lymphocytes 10%~15%
hematocrit value and hemoglobin rise
thrombocytopenia
Q: Viral infections causing leukocytosis
61
Laboratory test
• Urine tests :
Proteinuria (abnormally high amounts of
protein in the urine. )
Hematuria
Casts ( 管型 )
may be found in 2 days of diseases course
62
Massive protein and shedded epithelial cells in
urine form Membrane-like substance
Laboratory test
• Biochemical assay
Elevated PT/APTT or prolonged bleeding time.
Elevated liver enzymes, blood urea nitrogen
(BUN), and serum creatinine
Electrolyte abnormalities
64
Laboratory test
Etiological diagnosis
Enzyme-linked immunosorbent assay (ELISA)
65
Diagnosis
• Epidemiology:
a history of exposure in an endemic area.
• Clinical manifestations: 5 stages, atypical cases
have overlapping or bypass stages.
• 三痛 : pains of three body sites, e.g. headache, lumbar
pain and pain on ocular movement. 三红 :
blushes of three body sites, e.g. flushing over
face, the V area of the neck (drunken face) and
upper chest area.
• When the body temperature drops, the condition
deteriorates (“ 热退病进” ).
66
Laboratory findings
• Progressive thrombocytopenia, left-shifted
leukocytosis, presence of abnormal lymphocyte,
abnormal renal function, positive urine protein
Etiological diagnosis
67
Complications
• Neurological complications: encephalitis,
cerebral hemorrhage, etc.
• Pulmonary edema
• Rupture of kidney
• chronic renal failure
68
Differential diagnosis
1. In febrile phase
2. In Hypotensive phase
69
4. Oliguria and renal failure with acute nephritis
5. Pyrexia and hemorrhage with Leptospirosis
6. Marked hemorrhage with:
thrombocytopenic purpura,
gastrointestinal bleeding caused by gastric ulcer
70
Prognosis
Fatality is related to clinical type, whether being
treated earlier.
mortality 1%~5%.
major reasons for death:
renal failure, cerebrohernia
secondary infection/septicemia
massive bleeding.
mortality higher in patients with type I (Hantann)
virus infection.
71
Treatment
No specific treatment !
So the management of the patient must be
supportive and based on an understanding of the
pathophysiologic characteristics of the disease, and
an evaluation of clinical and/or laboratory findings.
Early diagnosis and hospitalization are most
important.
72
Treatment in febrile phase
73
Treatment in febrile phase
74
Treatment in hypotensive phase
Principle of treatment:
►Supplement blood volume
► Correct acidosis
76
2>Correct metabolic acidosis
77
Treatment in oliguric phase
Maintenance of internal environment homeostasis
Restrict the volume of infusion
Daily urine volume + 500-700ml
Control the azotemia
Supply sufficient carbohydrate to reduce the protein
degradation
Maintaining electrolyte balance
Treatment of Hyperkalemia
Correction of acidosis
5% Sodium Bicarbonate Injection
78
Treatment in oliguric phase
Diuretics: furosemide [fjʊə‘rəʊsəmaɪd] 速尿
• Consider hemodialysis in following conditions:
Severe azotemia
diuretics
Hyperkalemia refractory to medical therapy
79
Treatment in Diuretic phase
80
Treatment in Convalescent phase
81
Prevention
• Control source of infectin: Rodent control
• Cut off the route of transmission:
Avoid contact with rodent urine, droppings,
saliva, and nesting materials
• Protect susceptible people: inject specific
vaccine.
Inactivated hantavirus vaccine (IHV), DNA
vaccine.
Jung J, Ko SJ, Oh HS, et al. Protective effectiveness of inactivated hantavirus vaccine against
hemorrhagic fever with renal syndrome. J Infect Dis. 2018 Jan 24. doi: 10.1093/infdis/jiy037. 82
Summary
• 汉坦老鼠欧亚流
热血休克肾脏损
热退病进系统累
三红三痛五期过
白游板少尿蛋白
病急对症预防重
83
Home work
1. The main reason for early shock in HFRS is
A. Infection.
B. Blood plasma-losing
C. Hypervolemia
D. Hemorrhage
E. Vomiting .
84
Home work
2. The patient had fever, lumbago, headache for
three days. Physical examination: drunken face,
petechiae in axillary folds, chemosis. Blood
routine test: WBC 19×109 /L , N 83%, PLT
20×109 /L. Urine protein (+++), RBC 3-5/HP .The
diagnosis may be
A.Typhoid fever
B.Typhus
C.Acute glumerulonephritis
D.Epidemic hemorrhagic fever
85
Home work
3. Typical hemorrhagic fever with renal
syndrome caused by Hantaan virus evolve in
five identifiable stages:______, ______,
______, ______ and ______.
4. Give a introduction about the management
principle of the oliguric phase of the
hemorrhagic fever with renal syndrome
86
Case report
Male, 30 years old, farmer. he was admitted because of
fever, headache and lumbar pain for 4 days. he was in good
health in the past. PE: T 39℃, BP 110/70mmHg, flushing
on the face, conjunctival congestion, petechiae are
observed in the axillary folds. Both of lung were clear, and
the heart rate was normal. The abdomen was flat and soft ,
the liver and the spleen couldn’t be palpable, lightly
percussion pain in renal region, shifting dullness negative.
Laboratory findings:
Blood routine: WBC: 15×109/L, PLT: 70×109/L
Urine routine: protein + , BUN: 20mmol/L.CR:
433umol/L.
Case
88
89